Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
The operational handbook provides information on how to implement the WHO recommendations, tools, job-aids, and monitoring and evaluation indicators for the programmatic management of tuberculosis preventive treatment. The Module 1 handbook complements Module 1 of the WHO consolidated guidelines on tuberculosis.
The resource provides recommendations for the programmatic management of tuberculosis preventive treatment. Modules of the WHO consolidated guidelines on tuberculosis are complemented by matching modules of the WHO operational handbook on tuberculosis.
The guide details messaging and strategies to help advocates and activists ensure that the LAM test is made available in-country.
This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.
This guide details the latest WHO recommendations, TB diagnostic tools, and how these diagnostic tools should be used in country programs. The guide also provides activists with the information needed to advocate for access to TB diagnostic testing.
This material aims to inform national TB Programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in 2020.
The website includes various resources that were developed to address the difficulties that HIV programs might encounter when implementing TB preventive treatment. Programs can adapt the tools as needed.
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
This report, updated annually, details the global epidemiology of TB based on the data supplied by the national TB programs from WHO member states.
